AdaptHealth posts Q3 loss due to goodwill impairment charge

What happened

AdaptHealth's third-quarter revenue rose 10.9% from a year earlier and slightly missed analyst expectations. The company posted a $152.77 mln net loss and a $1.13 loss per share, driven by a $184.8 mln goodwill impairment charge, which means a writedown of intangible asset value.

Confirmed

Global impact / market context

The accounting charge turns reported profit into a large loss even though revenue grew, so investors must separate the one-time writedown from operating performance. Adjusted EBITDA, a profit measure excluding such items, fell 2.9%, and the lowered free cash flow forecast signals tighter cash generation.

Analyst inference

The company raised its 2026 revenue and adjusted EBITDA guidance but cut its free cash flow forecast. Analysts currently rate the shares buy, and the pending sale of the Diabetes Health business is meant to sharpen focus on core segments.

Analyst inference

What to watch

1. Watch whether the pending sale of the Diabetes Health business closes, since AdaptHealth says it will allow greater focus on Sleep Health, Respiratory Health and Wellness at Home core segments. Confirmed
2. Track whether the raised 2026 revenue and adjusted EBITDA guidance are met despite the lowered free cash flow forecast, since those targets are company projections rather than reported results. Proposed
3. Monitor the exclusive capitated agreement, which means fixed per-patient payments, to see if lower labor costs keep supporting contract profitability as revenue grows across segments. Analyst inference

Evidence

• Original source link unavailable